NO20000992L - FremgangsmÕter som benytter fag-display for Õ seleksjon av internaliserende ligander for genavlevering - Google Patents
FremgangsmÕter som benytter fag-display for Õ seleksjon av internaliserende ligander for genavleveringInfo
- Publication number
- NO20000992L NO20000992L NO20000992A NO20000992A NO20000992L NO 20000992 L NO20000992 L NO 20000992L NO 20000992 A NO20000992 A NO 20000992A NO 20000992 A NO20000992 A NO 20000992A NO 20000992 L NO20000992 L NO 20000992L
- Authority
- NO
- Norway
- Prior art keywords
- selection
- methods
- phage display
- gene delivery
- internalizing ligands
- Prior art date
Links
- 238000001476 gene delivery Methods 0.000 title 1
- 239000003446 ligand Substances 0.000 title 1
- 238000000034 method Methods 0.000 title 1
- 238000002823 phage display Methods 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C40—COMBINATORIAL TECHNOLOGY
- C40B—COMBINATORIAL CHEMISTRY; LIBRARIES, e.g. CHEMICAL LIBRARIES
- C40B40/00—Libraries per se, e.g. arrays, mixtures
- C40B40/02—Libraries contained in or displayed by microorganisms, e.g. bacteria or animal cells; Libraries contained in or displayed by vectors, e.g. plasmids; Libraries containing only microorganisms or vectors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
- A61K47/6901—Conjugates being cells, cell fragments, viruses, ghosts, red blood cells or viral vectors
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
- C12N15/1034—Isolating an individual clone by screening libraries
- C12N15/1037—Screening libraries presented on the surface of microorganisms, e.g. phage display, E. coli display
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6811—Selection methods for production or design of target specific oligonucleotides or binding molecules
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6897—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids involving reporter genes operably linked to promoters
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2799/00—Uses of viruses
- C12N2799/02—Uses of viruses as vector
- C12N2799/021—Uses of viruses as vector for the expression of a heterologous nucleic acid
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Wood Science & Technology (AREA)
- Genetics & Genomics (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- General Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Physics & Mathematics (AREA)
- Immunology (AREA)
- Analytical Chemistry (AREA)
- Biomedical Technology (AREA)
- Medicinal Chemistry (AREA)
- Virology (AREA)
- Hematology (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Plant Pathology (AREA)
- Cell Biology (AREA)
- Crystallography & Structural Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US5706797P | 1997-08-29 | 1997-08-29 | |
| PCT/US1998/017949 WO1999010485A1 (fr) | 1997-08-29 | 1998-08-28 | Procedes utilisant une presentation de phage pour selectionner des ligands internalisants en vue d'une administration de gene |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO20000992D0 NO20000992D0 (no) | 2000-02-28 |
| NO20000992L true NO20000992L (no) | 2000-03-27 |
Family
ID=22008306
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20000992A NO20000992L (no) | 1997-08-29 | 2000-02-28 | FremgangsmÕter som benytter fag-display for Õ seleksjon av internaliserende ligander for genavlevering |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US6472146B1 (fr) |
| EP (1) | EP1009819A1 (fr) |
| JP (1) | JP2001513995A (fr) |
| AU (1) | AU740541B2 (fr) |
| CA (1) | CA2302292A1 (fr) |
| NO (1) | NO20000992L (fr) |
| RU (1) | RU2234530C2 (fr) |
| WO (1) | WO1999010485A1 (fr) |
Families Citing this family (39)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6443974B1 (en) | 1996-07-28 | 2002-09-03 | Biosense, Inc. | Electromagnetic cardiac biostimulation |
| CA2302292A1 (fr) | 1997-08-29 | 1999-03-04 | Selective Genetics, Inc. | Procedes utilisant une presentation de phage pour selectionner des ligands internalisants en vue d'une administration de gene |
| US6451527B1 (en) * | 1997-08-29 | 2002-09-17 | Selective Genetics, Inc. | Methods using genetic package display for selecting internalizing ligands for gene delivery |
| US6589730B1 (en) | 1997-08-29 | 2003-07-08 | Selective Genetics, Inc. | Methods for identifying protein-protein interactions by selective transduction |
| US6723512B2 (en) * | 1997-08-29 | 2004-04-20 | Selective Genetics Inc. | Methods using genetic package display for detecting and identifying protein-protein interactions that facilitate internalization and transgene expression and cells or tissues competent for the same and methods for evolving gene delivery vectors |
| US6054312A (en) | 1997-08-29 | 2000-04-25 | Selective Genetics, Inc. | Receptor-mediated gene delivery using bacteriophage vectors |
| ES2255155T3 (es) | 1998-02-05 | 2006-06-16 | Biosense Webster, Inc. | Dispositivo para la administracion intracardiaca de farmacos. |
| GB9908195D0 (en) * | 1999-04-09 | 1999-06-02 | Microbiological Res Authority | Treatment of intracellular infection |
| AU7473500A (en) * | 1999-09-01 | 2001-03-26 | University Of Pittsburgh | Identification of peptides that facilitate uptake and cytoplasmic and/or nucleartransport of proteins, dna and viruses |
| SE0000597D0 (sv) * | 2000-02-24 | 2000-02-24 | Active Biotech Ab | Novel antibody |
| US20010041349A1 (en) * | 2000-04-17 | 2001-11-15 | Andrew Patron | Protein expression system arrays and use in biological screening |
| AU2001278968A1 (en) * | 2000-07-19 | 2002-01-30 | Pointilliste, Inc. | Nested sorting and high throughput screening |
| US7045283B2 (en) | 2000-10-18 | 2006-05-16 | The Regents Of The University Of California | Methods of high-throughput screening for internalizing antibodies |
| US7091046B2 (en) | 2000-12-11 | 2006-08-15 | Hk Pharmaceuticals, Inc. | Multiplexed protein expression and activity assay |
| GB0115385D0 (en) * | 2001-06-22 | 2001-08-15 | Regma Biotechnologies Ltd | Novel preparation |
| US20030143612A1 (en) * | 2001-07-18 | 2003-07-31 | Pointilliste, Inc. | Collections of binding proteins and tags and uses thereof for nested sorting and high throughput screening |
| AU2003205186A1 (en) * | 2002-01-16 | 2003-09-02 | Regents Of The University Of California | Functional ligand display |
| EP1474504A2 (fr) * | 2002-01-24 | 2004-11-10 | Pointilliste, Inc. | Utilisation de collections de sites de liaison pour etablir des profils d'echantillons et autres applications |
| JP2005325055A (ja) * | 2004-05-14 | 2005-11-24 | Peptide Door Co Ltd | リガンド結合タンパク質含有複合体及びリガンド結合タンパク質に結合する物質のスクリーニング方法 |
| US20080124355A1 (en) | 2006-09-22 | 2008-05-29 | David Gordon Bermudes | Live bacterial vaccines for viral infection prophylaxis or treatment |
| RU2009124649A (ru) | 2006-12-12 | 2011-01-20 | Морфосис Аг (De) | Интернализация |
| US8647642B2 (en) | 2008-09-18 | 2014-02-11 | Aviex Technologies, Llc | Live bacterial vaccines resistant to carbon dioxide (CO2), acidic PH and/or osmolarity for viral infection prophylaxis or treatment |
| US8241623B1 (en) | 2009-02-09 | 2012-08-14 | David Bermudes | Protease sensitivity expression system |
| SG173627A1 (en) | 2009-02-13 | 2011-09-29 | Chem Inc X | Methods of creating and screening dna-encoded libraries |
| WO2010094027A1 (fr) * | 2009-02-13 | 2010-08-19 | X-Body, Inc. | Identification de véhicules d'administration d'acides nucléiques faisant appel à l'affichage adn |
| RU2422520C1 (ru) * | 2009-11-30 | 2011-06-27 | Федеральное государственное учреждение здравоохранения "Ростовский-на-Дону ордена Трудового Красного Знамени научно-исследовательский противочумный институт" Федеральной службы по надзору в сфере защиты прав потребителей и благополучия человека | Способ получения и регистрации меченых бактериофагов на модели холерных вибрионов |
| US8771669B1 (en) | 2010-02-09 | 2014-07-08 | David Gordon Bermudes | Immunization and/or treatment of parasites and infectious agents by live bacteria |
| US9597379B1 (en) | 2010-02-09 | 2017-03-21 | David Gordon Bermudes | Protease inhibitor combination with therapeutic proteins including antibodies |
| US8524220B1 (en) | 2010-02-09 | 2013-09-03 | David Gordon Bermudes | Protease inhibitor: protease sensitivity expression system composition and methods improving the therapeutic activity and specificity of proteins delivered by bacteria |
| RU2425872C1 (ru) * | 2010-04-21 | 2011-08-10 | Федеральное государственное учреждение здравоохранения "Ростовский-на-Дону ордена Трудового Красного Знамени научно-исследовательский противочумный институт" Федеральной службы по надзору в сфере защиты прав потребителей и благополучия человека | ШТАММ БАКТЕРИЙ Yersinia enterocolitica, ИСПОЛЬЗУЕМЫЙ В КАЧЕСТВЕ ИНДИКАТОРНОЙ КУЛЬТУРЫ ДЛЯ ВЫЯВЛЕНИЯ УМЕРЕННЫХ БАКТЕРИОФАГОВ ЛИЗОГЕННЫХ ШТАММОВ О1, О3, О12 СЕРОВАРОВ |
| DK2748357T3 (en) | 2011-09-07 | 2018-07-16 | X Chem Inc | Methods for labeling DNA-encoded libraries |
| KR102146721B1 (ko) | 2012-07-13 | 2020-08-21 | 엑스-켐, 인크. | 폴리머라제에 의해 판독가능하지 않은 코딩 올리고뉴클레오티드 연결을 갖는 dna-코딩된 라이브러리 |
| US9593339B1 (en) | 2013-02-14 | 2017-03-14 | David Gordon Bermudes | Bacteria carrying bacteriophage and protease inhibitors for the treatment of disorders and methods of treatment |
| US9737592B1 (en) | 2014-02-14 | 2017-08-22 | David Gordon Bermudes | Topical and orally administered protease inhibitors and bacterial vectors for the treatment of disorders and methods of treatment |
| US10676723B2 (en) | 2015-05-11 | 2020-06-09 | David Gordon Bermudes | Chimeric protein toxins for expression by therapeutic bacteria |
| US11180535B1 (en) | 2016-12-07 | 2021-11-23 | David Gordon Bermudes | Saccharide binding, tumor penetration, and cytotoxic antitumor chimeric peptides from therapeutic bacteria |
| EP3577258B1 (fr) * | 2017-01-31 | 2024-11-27 | 48Hour Discovery Inc. | Présentation de molécules sur des nanosupports génétiquement codés silencieusement pour déterminer des interactions moléculaires synergiques |
| US12391939B2 (en) | 2018-07-23 | 2025-08-19 | The Governors Of The University Of Alberta | Genetically-encoded bicyclic peptide libraries |
| WO2020180971A1 (fr) * | 2019-03-04 | 2020-09-10 | The Texas A&M University System | Procédés de fabrication et d'utilisation de bibliothèques d'affichage de bactériophages à ambre imposé |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2139598T3 (es) * | 1990-07-10 | 2000-02-16 | Medical Res Council | Procedimientos para la produccion de miembros de parejas de union especifica. |
| US5733731A (en) | 1991-10-16 | 1998-03-31 | Affymax Technologies N.V. | Peptide library and screening method |
| US5516637A (en) * | 1994-06-10 | 1996-05-14 | Dade International Inc. | Method involving display of protein binding pairs on the surface of bacterial pili and bacteriophage |
| WO1997000271A1 (fr) * | 1995-06-14 | 1997-01-03 | The Regents Of The University Of California | Nouveaux anticorps humains a forte affinite diriges contre des antigenes tumoraux |
| GB9516138D0 (en) * | 1995-08-05 | 1995-10-04 | Medical Res Council | Improvements in or relating to methods of screening substances |
| AU3737297A (en) | 1996-08-05 | 1998-02-25 | Brigham And Women's Hospital | Bacteriophage-mediated gene therapy |
| US5955275A (en) * | 1997-02-14 | 1999-09-21 | Arcaris, Inc. | Methods for identifying nucleic acid sequences encoding agents that affect cellular phenotypes |
| WO1998039482A1 (fr) | 1997-03-07 | 1998-09-11 | Sunol Molecular Corporation | Proteines de fusion comprenant une proteine bacteriophage de revetement et un recepteur de cellule a chaine unique |
| CA2302292A1 (fr) | 1997-08-29 | 1999-03-04 | Selective Genetics, Inc. | Procedes utilisant une presentation de phage pour selectionner des ligands internalisants en vue d'une administration de gene |
-
1998
- 1998-08-28 CA CA002302292A patent/CA2302292A1/fr not_active Abandoned
- 1998-08-28 RU RU2000107788/13A patent/RU2234530C2/ru not_active IP Right Cessation
- 1998-08-28 WO PCT/US1998/017949 patent/WO1999010485A1/fr not_active Ceased
- 1998-08-28 EP EP98942312A patent/EP1009819A1/fr not_active Withdrawn
- 1998-08-28 AU AU90398/98A patent/AU740541B2/en not_active Ceased
- 1998-08-28 JP JP2000507793A patent/JP2001513995A/ja not_active Withdrawn
- 1998-11-17 US US09/195,379 patent/US6472146B1/en not_active Expired - Fee Related
-
2000
- 2000-02-28 NO NO20000992A patent/NO20000992L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| RU2234530C2 (ru) | 2004-08-20 |
| EP1009819A1 (fr) | 2000-06-21 |
| NO20000992D0 (no) | 2000-02-28 |
| JP2001513995A (ja) | 2001-09-11 |
| CA2302292A1 (fr) | 1999-03-04 |
| AU740541B2 (en) | 2001-11-08 |
| US6472146B1 (en) | 2002-10-29 |
| AU9039898A (en) | 1999-03-16 |
| WO1999010485A1 (fr) | 1999-03-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20000992D0 (no) | Fremgangsmõter som benytter fag-display for õ seleksjon av internaliserende ligander for genavlevering | |
| NO20004523L (no) | Avleveringssystem for Õ modulere immunrespons | |
| DE69804609D1 (de) | Spender mit zähleinrichtung der dosiseinheiten | |
| ATE450139T1 (de) | Verbesserter tropfbewässerungsauslass | |
| DE69839370D1 (de) | Einlass für Medikamenteninfusionspumpe | |
| FI963217A7 (fi) | Nestemäinen oftalminen, hidastetusti vapauttava antosysteemi | |
| DE69823784D1 (de) | Spender für streichfähige produkte | |
| AU3910400A (en) | Graph-based visual navigation through spatial environments | |
| AU2001234746A1 (en) | Sustained-release microencapsulated delivery system | |
| MXPA02009326A (es) | Sistema exhibidor de panel de mercancia. | |
| DE60014589D1 (de) | System zur interaktiven verteilung von wählbaren vorstellungen | |
| DE69833808D1 (de) | Interaktive Zeitspannenanzeige | |
| FI972866L (fi) | Kaksoisnestesuutin | |
| PT1207867E (pt) | Formas de administracao farmaceuticas orais retardadas contendo tramadol | |
| DE69813961D1 (de) | Plasmaanzeige | |
| NO20002478D0 (no) | Apparat for utdeling av fluid | |
| DK1023268T3 (da) | Isoquinoliner som urokinaseinhibitorer. | |
| DE59812804D1 (de) | Spender für Medien | |
| FI981968L (fi) | Nousuputken riippuva kannatus | |
| NO20001523D0 (no) | Fremgangsmåte for fremstilling av flytende hydrokarboner | |
| DE60018461D1 (de) | Fluidunterstützender teilchenspender | |
| NO974277D0 (no) | Dyse for væskeavgivelse | |
| IT1296524B1 (it) | Espositore per elementi ruotanti | |
| IT1287701B1 (it) | Cavalletto con o senza ruote per secchio portastrizzatore. | |
| FI972373A0 (fi) | Foerfarande foer reglering av hastigheten hos en hiss och hissystem |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |